Source: Annual Congress 2003 - Pharmacological treatment strategies in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Forkert, D. O'Donnell (Kingston, Canada). Flow-volume responsiveness to bronchodilators in COPD. Eur Respir J 2003; 22: Suppl. 45, 442

Member's Comments

No comment yet.

Related content which might interest you: COPD and airway responsiveness to beta-agonists Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III Year: 2007 Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Airway inflammation and inhaled corticosteroids in COPD Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017 Year: 2017 Assessing regional airways responses to inhaled bronchodilators in asthmatics Source: Annual Congress 2010 - Airways mechanics in different applications Year: 2010 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 Year: 2017 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017 Year: 2017 Bronchodilator treatment for asthma and COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 Bronchodilator responsiveness in patients with COPD Source: Eur Respir J 2008; 31: 742-750 Year: 2008 Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Paradoxical bronchoconstriction after administration of beta-2 agonist bronchodilators in COPD patients Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Variability in asthma severity among steroid-naive patients previously receiving short-acting beta2-agonists Source: Eur Respir J 2003; 22: Suppl. 45, 410s Year: 2003 Changes in airway and tissue mechanics in ventilated COPD patients after nebulized bronchodilator agent Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007 COPD: Comparison of bronchodilator responsiveness with glycopyrronium and salbutamol Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Nebulized bronchodilator therapy in stable COPD – effect on quality of life and spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 64s Year: 2006 How the bronchodilatator in COPD patients works Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004 Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Effect of inhaled bronchodilators on the neurovegetative status of patients with bronchial asthma Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008